We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

316 hedge funds and large institutions have $1.97B invested in Takeda Pharmaceutical in 2021 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 107 increasing their positions, 70 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 70

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

14% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 49

1% more funds holding

Funds holding: 312 → 316 (+4)

7% more call options, than puts

Call options by funds: $95.8M | Put options by funds: $89.6M

0.06% less ownership

Funds ownership: 6.9% → 6.84% (-0.06%)

0% less capital invested

Capital invested by funds: $1.98B → $1.97B (-$9.29M)

Holders
316
Holders Change
+4
Holders Change %
+1.28%
% of All Funds
5.55%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
56
Increased
107
Reduced
70
Closed
49
Calls
$95.8M
Puts
$89.6M
Net Calls
+$6.19M
Net Calls Change
+$12M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$182M
2
First Trust Advisors
First Trust Advisors
Illinois
+$33.5M
3
BlackRock
BlackRock
New York
+$24.6M
4
GCM
Glenview Capital Management
New York
+$15.2M
5
Bank of America
Bank of America
North Carolina
+$13.2M

Top Sellers

Rank Fund Capital Flow
1
AC
Adelphi Capital
United Kingdom
-$138M
2
PC
Paulson & Co
New York
-$118M
3
Renaissance Technologies
Renaissance Technologies
New York
-$38.6M
4
TAM
TFG Asset Management
Cayman Islands
-$15.4M
5
RJA
Raymond James & Associates
Florida
-$14.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
$3.45M -$173K -9,598 -5%
Comerica Bank
52
Comerica Bank
Texas
$3.28M +$115K +6,372 +3%
RCM
53
Redwood Capital Management
New York
$3.25M -$2.47M -137,191 -44%
LP
54
LMR Partners
United Kingdom
$3.2M +$3.16M +175,644 New
Twin Tree Management
55
Twin Tree Management
Texas
$3.05M -$3.64M -202,113 -55%
EGA
56
Eagle Global Advisors
Texas
$2.87M -$66.4K -3,689 -2%
RJFSA
57
Raymond James Financial Services Advisors
Florida
$2.69M +$1.35M +74,856 +104%
CSS
58
Cubist Systematic Strategies
Connecticut
$2.62M +$1.74M +96,771 +208%
Legal & General Group
59
Legal & General Group
United Kingdom
$2.54M – – –
Commonwealth Equity Services
60
Commonwealth Equity Services
Massachusetts
$2.53M +$750K +41,674 +43%
MS
61
Mizuho Securities
Japan
$2.53M +$2.49M +138,545 New
Millennium Management
62
Millennium Management
New York
$2.51M +$2.47M +137,449 New
Pacer Advisors
63
Pacer Advisors
Pennsylvania
$2.41M -$129K -7,185 -5%
SGI
64
Summit Global Investments
Utah
$2.36M -$1.31M -72,577 -36%
Jane Street
65
Jane Street
New York
$2.3M +$1.47M +81,794 +178%
LK
66
Lumbard & Kellner
New Hampshire
$2.26M -$14.9K -828 -0.6%
KM
67
Kalos Management
Georgia
$2.23M +$811K +45,074 +51%
HFS
68
Hantz Financial Services
Michigan
$2.11M +$2.08M +115,587 New
CCA
69
Catalyst Capital Advisors
New York
$2.05M +$432K +24,000 +27%
MWNA
70
Marshall Wace North America
New York
$2.04M +$741K +41,196 +58%
EIP
71
Epoch Investment Partners
New York
$1.98M -$16.7K -930 -0.8%
Osaic Holdings
72
Osaic Holdings
Arizona
$1.95M +$232K +12,906 +14%
FIA
73
FNY Investment Advisers
New York
$1.88M +$1.85M +102,988 New
Two Sigma Advisers
74
Two Sigma Advisers
New York
$1.84M +$1.81M +100,800 New
BC
75
Blackcrane Capital
Washington
$1.72M -$372K -20,665 -59%
1 2
3
4 5

TAK Hedge Fund Activity: Q1 2021 in Review

316 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q1 2021, worth a combined $1.97B — down 0.47% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TAK positions and 49 closed out — a net gain of 7 holders — while 107 added to existing stakes and 70 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $182M. The largest seller was Adelphi Capital, exiting entirely with an estimated $138M sold.

  • 316 institutional investors held Takeda Pharmaceutical (TAK) as of Q1 2021, up from 312 in Q4 2020.
  • Funds reported $1.97B of Takeda Pharmaceutical stock for Q1 2021, down 0.47% quarter-over-quarter.
  • 56 funds opened new Takeda Pharmaceutical positions in Q1 2021 and 49 closed out, a net change of +7 holders.
  • The largest Takeda Pharmaceutical buyer in Q1 2021 was ARK Investment Management, an estimated $182M added.
  • The largest Takeda Pharmaceutical seller in Q1 2021 was Adelphi Capital, an estimated $138M sold.

Based on aggregated 13F filings for Q1 2021.